|
Abou-Douh, A.M. 2002. New withanolides and other constituents from the fruit of Withania somnifera. Arch Pharm (Weinheim). 335, 267-276.
Abraham, R.T. 2001. Cell cycle checkpoint signaling through the ATM and ATR kinases. Genes Dev. 15, 2177-2196.
Adams, J.M., Cory, S., 1998. The Bcl-2 protein family: arbiters of cell survival. Science. 281, 1322-1326.
Ali, A.M., Mackeen, M.M., Hamid, M., Aun, Q.B., Zauyah, Y., Azimahtol, H.L., Kawazu, K., 1997. Cytotoxicity and electron micreactive oxygen speciescopy of cell death induced by goniothalamin. Planta Med. 63, 81-83.
Ambrosini, G., Adida, C., Altieri, D.C. 1997. A novel anti-apoptosis gene, survivin, expressed in cancer and lymphoma. Nat Med. 3, 917-921.
An, W.G., Schulte, T.W., Neckers, L.M. 2000. The heat shock protein 90 antagonist geldanamycin alters chaperone association with p210bcr-abl and v-src proteins before their degradation by the proteasome. Cell Growth Differ. 11, 355-360.
Aoshiba, K., Yasui, S., Nishimura, K., Nagai, A., 1999. Thiol depletion induces apoptosis in cultured lung fibroblasts. Am J Respir Cell Mol Biol. 21, 54-64.
Arora, A., Scholar, E.M. 2005. Role of tyrosine kinase inhibitors in cancer therapy. J Pharmacol Exp Ther. 15, 971-979.
Azimahtol, H.L.P., Munawer, M., Din, L.B., 1994. Anti-fertility effect of goniothalamin: a styrylpyrone isolated from Goniothalamus tapis Miq. Asia Pacific J Pharmacol. 9, 273-277.
Bagatell, R., Whitesell, L. 2004. Altered Hsp90 function in cancer: a unique therapeutic opportunity. Mol Cancer Ther. 3, 1021-1030.
Bali, P., Pranpat, M., Bradner, J., Balasis, M., Fiskus, W., Guo, F., Rocha, K., Kumaraswamy, S., Boyapalle, S., Atadja, P., Seto, E., Bhalla, K. 2005. Inhibition of histone deacetylase 6 acetylates and disrupts the chaperone function of heat shock protein 90: a novel basis for antileukemia activity of histone deacetylase inhibitors. J Biol Chem. 280, 26729-26734.
Barbu, A., Welsh, N., Saldeen, J., 2002. Cytokine-induced apoptosis and necrosis are preceded by disruption of the mitochondrial membrane potential (Deltapsi(m)) in pancreatic RINm5F cells: prevention by Bcl-2. Mol Cell Endocrinol. 190, 75-82.
Basso, A.D., Solit, D.B., Chiosis, G., Girim, B., Tsichlis, P., Rosen, N. 2002. Akt forms an intracellular complex with heat shock protein 90 (Hsp90) and Cdc37 and is destabilized by inhibitors of Hsp90 function. J Biol Chem. 277, 39858-39866.
Benhar, M., Dalyot, I., Engelberg, D., Levitzki, A. 2001. Enhanced ROS production in oncogenically transformed cells potentiates c-Jun N-terminal kinase and p38 mitogen-activated protein kinase activation and sensitization to genotoxic stress. Mol Cell Biol. 21, 6913-6926.
Blázquez, M.A , Bermejo, A., Zafra-Polo, M.C., Cortes, D., 1999. Styryl-lactones from Goniothalamus species - a review. Phytochem Anal. 10,161-170.
Bruey, J.M., Ducasse, C., Bonniaud, P., Ravagnan, L., Susin, S.A., Diaz-Latoud, C., Gurbuxani, S., Arrigo, A.P., Kroemer, G., Solary, E., Garrido, C. 2000. Hsp27 negatively regulates cell death by interacting with cytochrome c. Nat Cell Biol. 2, 645-652.
Buchner, J. 1999. Hsp90 & Co. - a holding for folding. Trends Biochem Sci. 24, 136-141.
Bunz, F., Dutriaux, A., Lengauer, C., Waldman, T., Zhou, S., Brown, J.P., Sedivy, J.M., Kinzler, K.W., Vogelstein, B., 1998. Requirement for p53 and p21 to sustain G2 arrest after DNA damage. Science. 282, 1497-1501.
Burris, H.A., Hurwitz, H.I., Dees, E.C., Dowlati, A., Blackwell, K.L., O''Neil, B., Marcom, P.K., Ellis, M.J., Overmoyer, B., Jones, S.F., Harris, J.L., Smith, D.A., Koch, K.M., Stead, A., Mangum, S., Spector, N.L. 2005. Phase I safety, pharmacokinetics, and clinical activity study of lapatinib (GW572016), a reversible dual inhibitor of epidermal growth factor receptor tyrosine kinases, in heavily pretreated patients with metastatic carcinomas. J Clin Oncol. 23, 5305-5313.
Buttke, T.M., SAndstrom, P.A., 1994. Oxidative stress as a mediator of apoptosis. Immunology Today. 15, 7-10.
Buzdar, A.U. 2003. Advances in endocrine treatments for postmenopausal women with metastatic and early breast cancer. Oncologist. 8, 335–341.
Cailleau, R., Olive, M., Crueiger, Q.V.J. 1978. Long term human breast carcinoma cell lines of metastatic origin: preliminary characterization. In Vitro. 14, 911-915.
Cain, K., Bratton, S.B., Cohen, G.M., 2002. The Apaf-1 apoptosome: a large caspase-activating complex. Biochimie. 84, 203-214.
Cantley, L.C., Neel, B.G. 1999. New insights into tumor suppression: PTEN suppresses tumor formation by restraining the phosphoinositide 3-kinase/AKT pathway. Proc Natl Acad Sci U S A. 96, 4240-4245.
Chen, C.J., You, S.L., Lin, L.H., Hsu, W.L., Yang, Y.W. 2002. Cancer epidemiology and control in Taiwan: a brief review. Jpn J Clin Oncol. 32 Suppl, S66-S81.
Chen, G., Cao, P., Goeddel, D.V. 2002. TNF-induced recruitment and activation of the IKK complex require Cdc37 and Hsp90. Mol Cell. 2, 401-410.
Chen, L., Gao, X. 2002. Neuronal apoptosis induced by endoplasmic reticulum stress. Neurochem Res. 27, 891-898.
Ciocca, D.R., Calderwood, S.K. 2005. Heat shock proteins in cancer: diagnostic, prognostic, predictive, and treatment implications. Cell Stress Chaperones. 10, 86-103.
Clarke, P.A., Hostein, I., Banerji, U., Stefano, F.D., Maloney, A., Walton, M., Judson, I., Workman, P. 2000. Gene expression profiling of human colon cancer cells following inhibition of signal transduction by 17-allylamino-17-demethoxygeldanamycin, an inhibitor of the hsp90 molecular chaperone. Oncogene. 19, 4125-4133.
Cobleigh, M.A., Langmuir, V.K., Sledge, G.W., Miller, K.D., Haney, L., Novotny, W.F., Reimann, J.D., Vassel, A. 2003. A phase I/II dose-escalation trial of bevacizumab in previously treated metastatic breast cancer. Semin Oncol. 30, 117–124.
Cory, S., Adams, J.M. 2002. The Bcl2 family: regulators of the cellular life-or-death switch. Nat Rev Cancer. 2, 647-656.
Cragg, G.M., Newman, D.J. 2005. Plants as a source of anti-cancer agents. J Ethnopharmacol. 100, 72-79.
Cumming, R.C., Andon, N.L., Haynes, P.A., Park, M., Fischer, W.H., Schubert, D. 2004. Protein disulfide bond formation in the cytoplasm during oxidative stress. J Biol Chem. 279, 21749-21758.
Dai, J., Weinberg, R.S., Waxman, S., Jing, Y. 1999. Malignant cells can be sensitized to undergo growth inhibition and apoptosis by arsenic trioxide through modulation of the glutathione redox system. Blood. 93, 268-277.
D''Arcy, W.G., Keating, R.C., Zhang, Z.Y., Peng, C.I. 2001. The genus Tubocapsicum (Solanaceae). Bot Bull Acad Sin. 42, 67-84.
Datta, S.R., Dudek, H., Tao, X., Masters, S., Fu, H., Gotoh, Y., Greenberg, M.E. 1997. Akt phosphorylation of BAD couples survival signals to the cell-intrinsic death machinery. Cell. 91, 231-241.
de Duve, C. 1983. Lysosomes revisited. Eur J Biochem. 137, 391-397.
De Giorgi, F., Lartigue, L., Bauer, M.K., Schubert, A., Grimm, S., Hanson, G.T., Remington, S.J., Youle, R.J., Ichas, F., 2002. The permeability transition pore signals apoptosis by directing Bax translocation and multimerization. FASEB J. 16, 607-609.
Demonty, G., Bernard-Marty, C., Puglisi, F., Mancini, I. Piccart, M. 2007. Progress and new standards of care in the management of HER-2 positive breast cancer. Eur J Cancer. 43, 497–509.
Deneke, S.M., 2000. Thiol-based antioxidants. Curr Top Cell Regul. 36, 151-180.
Deng, C.X., Scott, F. 2000. Role of the tumor suppressor gene Brca1 in genetic stability and mammary gland tumor formation. Oncogene. 19, 1059-1064.
Early Breast Cancer Trialists'' Collaborative Group (EBCTCG). 2005. Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials. Lancet. 365, 1687-1717.
Fearnhead, H.O., Dinsdale, D., Cohen, G.M. 1995. An interleukin-1 beta-converting enzyme-like protease is a common mediator of apoptosis in thymocytes. FEBS Lett. 375, 283-288.
Fernandez-Checa, J.C., 2003. Redox regulation and signaling lipids in mitochondrial apoptosis. Biochem Biophys Res Commun. 304, 471-479.
Ferri, K.F., Kroemer, G. 2001. Organelle-specific initiation of cell death pathways. Nat Cell Biol. 3, E255-E263.
Figueiredo-Pereira, M. E., Berg, K. A., Wilk, S. 1994. A new inhibitor of the chymotrypsin-like activity of the multicatalytic proteinase complex (20S proteasome) induces accumulation of ubiquitin-protein conjugates in a neuronal cell. J Neurochem. 63, 1578-1581.
Finucane, D.M., Waterhouse, N.J., Amarante-Mendes, G.P., Cotter, T.G., Green, D.R. 1999. Collapse of the inner mitochondrial transmembrane potential is not required for apoptosis of HL60 cells. Exp Cell Res. 251, 166-174.
Fulda, S., Debatin, KM. 2006. Extrinsic versus intrinsic apoptosis pathways in anticancer chemotherapy. Oncogene. 25, 4798-4811.
Fuller, K.J., Issels, R.D., Slosman, D.O., Guillet, J.G., Soussi, T., Polla, B.S. 1994. Cancer and the heat shock response. Eur J Cancer. 30A, 1884-1891.
Fuska, J., Fusková, A., Rosazza, J.P., Nicholas, A.W. 1984. Novel cytotoxic and antitumor agents. IV. Withaferin A: relation of its structure to the in vitro cytotoxic effects on P388 cells. Neoplasma. 31, 31-36.
Gabai, V.L., Budagova, K.R., Sherman, M.Y. 2005. Increased expression of the major heat shock protein Hsp72 in human prostate carcinoma cells is dispensable for their viability but confers resistance to a variety of anticancer agents. Oncogene. 24, 3328-3338.
Gagnon, J., Shaker, S., Primeau, M., Hurtubise, A., Momparler, R. L. 2003 Interaction of 5-aza-2''-deoxycytidine and depsipeptide on antineoplastic activity and activation of 14-3-3σ, E-cadherin and tissue inhibitor of metalloproteinase 3 expression in human breast carcinoma cells. Anti-Cancer Drugs. 14, 193-202.
Gamaley, I.A., Klyubin, I.V. 1999. Roles of reactive oxygen species: signaling and regulation of cellular functions. Int Rev Cytol. 188, 203-255.
Garrido, C., Galluzzi, L., Brunet, M., Puig, P.E., Didelot, C., Kroemer, G. 2006. Mechanisms of cytochrome c release from mitochondria. Cell Death Differ. 9, 1423-1433.
Gilot, D., Loyer, P., Corlu, A., Glaise, D., Lagadic-Gossmann, D., Atfi, A., Morel, F., Ichijo, H., Guguen-Guillouzo, C. 2002. Liver protection from apoptosis requires both blockage of initiator caspase activities and inhibition of ASK1/JNK pathway via glutathione S-transferase regulation. J Biol Chem. 277, 49220-49229.
Gorman, A.M, Heavey, B., Creagh, E, Cotter, T.G., Samali, A. 1999. Antioxidant-mediated inhibition of the heat shock response leads to apoptosis. FEBS Lett 445, 98–102.
Gowen, L.C., Johnson, B.L., Latour, A.M., Sulik, K.K., Koller, B.H. 1996. Brca1 deficiency results in early embryonic lethality characterized by neuroepithelial abnormalities. Nat Genet. 12, 191-194.
Green, D.R., Reed, J.C., 1998. Mitochondria and apoptosis. Science. 281, 1309-1312.
Guo, F., Rocha, K., Bali, P., Pranpat, M., Fiskus, W., Boyapalle, S., Kumaraswamy, S., Balasis, M., Greedy, B., Armitage, E.S., Lawrence, N., Bhalla, K. 2005. Abrogation of heat shock protein 70 induction as a strategy to increase antileukemia activity of heat shock protein 90 inhibitor 17-allylamino-demethoxy geldanamycin. Cancer Res. 65, 10536-10544.
Hakem, R., de la Pompa, J.L., Sirard, C., Mo, R., Woo, M., Hakem, A., Wakeham, A., Potter, J., Reitmair, A., Billia, F., Firpo, E., Hui, C.C., Roberts, J., Rossant, J., Mak, T.W. 1996. The tumor suppressor gene Brca1 is required for embryonic cellular proliferation in the mouse. Cell. 85, 1009-1023.
Hampton, M.B., Fadeel, B., Orrenius, S., 1998. Redox regulation of the caspases during apoptosis. Ann N Y Acad Sci. 854, 328-335.
Hanahan, D., Weinberg, R.A. 2000. The hallmarks of cancer. Cell. 100, 57-70.
Hancock, J.T., Desikan, R., Neill, S.J., 2001. Does the redox status of cytochrome c act as a fail-safe mechanism in the regulation of programmed cell death? Free Radic Biol Med. 31, 697-703.
Hartl, F.U., Hayer-Hartl, M. 2002. Molecular chaperones in the cytosol: from nascent chain to folded protein. Science. 295, 1852-1858.
Hartwell, L.H., Weinert, T.A. 1989. Checkpoints: controls that ensure the order of cell cycle events. Science. 246, 629-634.
Hawariah, A., Stanslas, J., 1998. In vitro response of human breast cancer cell lines to the growth-inhibitory effects of styrylpyrone derivative (SPD) and assessment of its antiestrogenicity. Anticancer Res. 18, 4383-4386.
Hayes, D.F., Miller, K., Sledge, G. 2007. Angiogenesis as targeted breast cancer therapy. Breast. 16, 17–19.
Hegde, R., Srinivasula, S.M., Zhang, Z., Wassell, R., Mukattash, R., Cilenti, L., DuBois, G., Lazebnik, Y., Zervos, A.S., Fernandes-Alnemri, T., Alnemri, E.S. 2002. Identification of Omi/HtrA2 as a mitochondrial apoptotic serine protease that disrupts inhibitor of apoptosis protein-caspase interaction. J Biol Chem. 277, 432-438.
Helt, C.E., Rancourt, R.C., Staversky, R.J., O''Reilly, M.A., 2001. p53-dependent induction of p21(Cip1/WAF1/Sdi1) protects against oxygen-induced toxicity. Toxicol Sci. 63, 214-222.
Henry-Mowatt, J., Dive, C., Martinou, J.C., James, D., 2004. Role of mitochondrial membrane permeabilization in apoptosis and cancer. Oncogene. 23, 2850-2860.
Hirao, A., Kong, Y.Y., Matsuoka, S., Wakeham, A., Ruland, J., Yoshida, H., Liu, D., Elledge, S.J., Mak, T.W. 2000. DNA damage-induced activation of p53 by the checkpoint kinase Chk2. Science. 287, 1824-1827.
Holmgren, A., Björnstedt, M. 1995. Thioredoxin and thioredoxin reductase. Methods Enzymol. 252, 199-208.
Hortobagyi, G.N. 2000. Developments in chemotherapy of breast cancer. Cancer. 88, 3073–3079.
Hsieh, P.W., Huang, Z.Y., Chen, J.H., Chang, F.R., Wu, C.C., Yang, Y.L., Chiang, M.Y., Yen, M.H., Chen, S.L., Yen, H.F., Lübken, T., Hung, W.C., Wu, Y.C. 2007. Cytotoxic withanolides from Tubocapsicum anomalum. J Nat Prod. 70, 747-753.
Huang, P., Feng, L., Oldham, E.A., Keating, M.J., Plunkett, W. 2000 Superoxide dismutase as a target for the selective killing of cancer cells. Nature. 407, 390-395.
Inayat-Hussain, S.H., Annuar, B.O., Din, L.B., Ali, A.M., Ross, D. 2003. Loss of mitochondrial transmembrane potential and caspase-9 activation during apoptosis induced by the novel styryl-lactone goniothalamin in HL-60 leukemia cells. Toxicol In Vitro. 17, 433-439.
Jäättelä, M. 1999. Escaping cell death: survival proteins in cancer. Exp Cell Res. 248, 30-43.
Jacobson, M.D., Weil, M., Raff, M.C. 1997. Programmed cell death in animal development. Cell. 88, 347-354.
Jameel, A., Skilton, R.A., Campbell, T.A., Chander, S.K., Coombes, R.C., Luqmani, Y.A. 1992. Clinical and biological significance of HSP89 alpha in human breast cancer. Int J Cancer. 50, 409-415.
Jin, Z., El-Deiry, W.S. 2005. Overview of cell death signaling pathways. Cancer Biol Ther. 4, 139-163.
Jolly, C., Morimoto, R.I. 2000. Role of the heat shock response and molecular chaperones in oncogenesis and cell death. J Natl Cancer Inst. 92, 1564-1572.
Juo, P., Kuo, C.J., Yuan, J., Blenis, J. 1998. Essential requirement for caspase-8/FLICE in the initiation of the Fas-induced apoptotic cascade. Curr Biol. 8, 1001-1008.
Kabir, K.E., Khan, A.R., Mosaddik, M.A., 2003. Goniothalamin-a potent mosquito larvicide from Bryonopsis laciniosa L. J Appl Ent. 127, 112-115.
Kannan, K., Jain, S.K. 2000. Oxidative stress and apoptosis. Pathophysiology. 7, 153-163.
Kastan, M.B. 2001. Cell cycle. Checking two steps. Nature. 410, 766-767.
Kaur, J., Kaur, J., Ralhan, R. 2000. Induction of apoptosis by abrogation of HSP70 expression in human oral cancer cells. Int J Cancer. 85, 1-5.
Kim, D.K., Cho, E.S., Seong, J.K., Um, H.D., 2001. Adaptive concentrations of hydrogen peroxide suppress cell death by blocking the activation of SAPK/JNK pathway. J Cell Sci. 114, 4329-4334.
King, M.C., Marks, J.H., Mandell, J.B. New York Breast Cancer Study Group. 2003. Breast and ovarian cancer risks due to inherited mutations in BRCA1 and BRCA2. Science. 302, 643-636.
Kluck, R.M., Bossy-Wetzel, E., Green, D.R., Newmeyer, D.D. 1997. The release of cytochrome c from mitochondria: a primary site for Bcl-2 regulation of apoptosis. Science. 275, 1132-1136.
Koepp, D.M., Harper, J.W., Elledge, S.J. 1999. How the cyclin became a cyclin: regulated proteolysis in the cell cycle. Cell. 97, 431-434.
Kuida, K., Haydar, T.F., Kuan, C.Y., Gu, Y., Taya, C., Karasuyama, H., Su, M.S., Rakic, P., Flavell, R.A. 1998. Reduced apoptosis and cytochrome c-mediated caspase activation in mice lacking caspase 9. Cell. 94, 325–337.
Kurata, S. 2000. Selective activation of p38 MAPK cascade and mitotic arrest caused by low level oxidative stress. J Biol Chem. 275, 23413-23416.
La Rosée, P., O''Dwyer, M.E., Druker, B.J. 2002. Insights from pre-clinical studies for new combination treatment regimens with the Bcr-Abl kinase inhibitor imatinib mesylate (Gleevec/Glivec) in chronic myelogenous leukemia: a translational perspective. Leukemia. 16, 1213-1219.
Lan, Y.H., Chang, F.R., Yu, J.H., Yang, Y.L., Chang, Y.L., Lee, S.J., Wu, Y.C. 2003. Cytotoxic styrylpyrones from Goniothalamus amuyon. J Nat Prod. 66, 487-490.
LeBel, C.P., Ischiropoulos, H., Bondy, S.C. 1992. Evaluation of the probe 2'',7''-dichlorofluorescin as an indicator of reactive oxygen species formation and oxidative stress. Chem Res Toxicol. 5, 227-231.
Lengauer, C., Kinzler, K.W., Vogelstein, B. 1998. Genetic instabilities in human cancers. Nature. 396, 643-649.
Li, Y., Upadhyay, S., Bhuiyan, M., Sarkar, F.H. 1999. Induction of apoptosis in breast cancer cells MDA-MB-231 by genistein. Oncogene. 18, 3166-3172.
Liang, J., Zubovitz, J., Petrocelli, T., Kotchetkov, R., Connor, M. K., Han, K., Lee, J. H., Ciarallo, S., Catzavelos, C., Beniston, R., Franssen, E., Slingerland, J. M. 2002. PKB/Akt phosphorylates p27, impairs nuclear import of p27 and opposes p27-mediated G1 arrest. Nat Med 8, 1153 -1160.
Liu, Q., Levy, E.J., Chirico, W.J. 1996a. N-Ethylmaleimide inactivates a nucleotide-free Hsp70 molecular chaperone. J Biol Chem. 271, 29937-29944.
Liu, X., Kim, C.N., Yang, J., Jemmerson, R., Wang, X. 1996b. Induction of apoptotic program in cell free extracts: Requirement for dATP and Cytochrome C. Cell. 86, 147-157.
Liu, X., Zou, H., Slaughter, C., Wang, X. 1997. DFF, a heterodimeric protein that functions downstream of caspase-3 to trigger DNA fragmentation during apoptosis. Cell. 89, 175-184.
Loo, G., 2003. Redox-sensitive mechanisms of phytochemical-mediated inhibition of cancer cell proliferation (review). J Nutr Biochem. 14, 64-73.
Lopez-Otin, C., Diamandis, E. P. 1998. Breast and prostate cancer: an analysis of common epidemiological, genetic, and biochemical features. Endocr Rev. 19, 365–396.
Luo, X., Budihardjo, I., Zou, H., Slaughter, C., Wang, X. 1998. Bid, a Bcl2 interacting protein, mediates cytochrome c release from mitochondria in response to activation of cell surface death receptors. Cell. 94, 481-490.
Ly, J.D., Grubb, D.R., Lawen, A. 2003. The mitochondrial membrane potential (deltapsi(m)) in apoptosis; an update. Apoptosis. 8, 115-128.
Lyon, M.A., Ducruet, A.P., Wipf, P., Lazo, J.S. 2002. Dual-specificity phosphatases as targets for antineoplastic agents. Nat Rev Drug Discov. 12, 961-976.
Marcu, M.G., Chadli, A., Bouhouche, I., Catelli, M., Neckers, L.M. 2000. The heat shock protein 90 antagonist novobiocin interacts with a previously unrecognized ATP-binding domain in the carboxyl terminus of the chaperone. J Biol Chem. 275, 37181-37186.
Martensson, J., Jain, A., Stole, E., Frayer, W., Auld, P.A., Meister, A. 1991. Inhibition of glutathione synthesis in the newborn rat: a model for endogenously produced oxidative stress. Proc Natl Acad Sci U S A. 88, 9360-9364.
Martindale, J.L., Holbrook, N.J. 2002. Cellular response to oxidative stress: signaling for suicide and survival. J Cell Physiol. 192, 1-15.
Michieli, P., Chedid, M., Lin, D., Propidium iodideerce, J.H., Mercer, W.E., Givol, D. 1994. Induction of WAF1/CIP1 by a p53-independent pathway. Cancer Res. 54, 3391-3395.
Mimnaugh, E. G., Chavany, C. Neckers, L. 1996. Polyubiquitination and proteasomal degradation of the p185c-erbB-2 receptor protein-tyrosine kinase induced by geldanamycin. J Biol Chem. 271, 22796–22801.
Minn, A.J., Vélez, P., Schendel, S.L., Liang, H., Muchmore, S.W., Fesik, S.W., Fill, M., Thompson, C.B. 1997. Bcl-x(L) forms an ion channel in synthetic lipid membranes. Nature. 385, 353-357.
Mirza, A.M., Gysin, S., Malek, N., Nakayama, K., Roberts, J.M., McMahon, M. 2004. Cooperative regulation of the cell division cycle by the protein kinases RAF and AKT. Mol Cell Biol. 24, 10868-10881.
Mishra, L.C., Singh, B.B., Dagenais, S. 2000. Scientific basis for the therapeutic use of Withania somnifera (ashwagandha): a review. Altern Med Rev. 5, 334-346.
Miyajima, A., Nakashima, J., Yoshioka, K., Tachibana, M., Tazaki, H., Murai, M. 1997. Role of reactive oxygen species in cis-dichlorodiammineplatinum-induced cytotoxicity on bladder cancer cells. Br J Cancer. 76, 206-210.
Morimoto, R.I. 1993. Cells in stress: transcriptional activation of heat shock genes. Science. 259, 1409-1410.
Mosaddik, M.A., Haque, M.E. 2003. Cytotoxicity and antimicrobial activity of goniothalamin isolated from Bryonopsis laciniosa. Phytother Res. 17, 1155-1157.
Mosmann, T. 1983. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods. 65, 55-63.
Mosser, D.D., Caron, A.W., Bourget, L., Denis-Larose, C., Massie, B. 1997. Role of the human heat shock protein hsp70 in protection against stress-induced apoptosis. Mol Cell Biol. 17, 5317-5327.
Mosser, D.D., Morimoto, R.I. 2004. Molecular chaperones and the stress of oncogenesis. Oncogene. 23, 2907-2918.
Moulder, S., Hortobagyi, G.N. 2008. Advances in the treatment of breast cancer. Clin Pharmacol Ther. 83, 26-36.
Murakami, Y., Uehara, Y., Yamamoto, C., Fukazawa, H., Mizuno, S. 1991. Induction of hsp 72/73 by herbimycin A, an inhibitor of transformation by tyrosine kinase oncogenes. Exp Cell Res. 195, 338-344.
Musacchio, A., Hardwick, K.G. 2002. The spindle checkpoint: structural insights into dynamic signalling. Nat Rev Mol Cell Biol. 10, 731-741.
Nakamura, H., Nakamura, K., Yodoi, J. 1997. Redox regulation of cellular activation. Annu Rev Immunol. 15, 351-369.
Nardai, G., Sass, B., Eber, J., Orosz, G., Csermely, P. 2000. Reactive cysteines of the 90-kDa heat shock protein, Hsp90. Arch Biochem Biophys. 384, 59-67.
Neckers, L. 2002. Heat shock protein 90 inhibition by 17-allylamino-17- demethoxygeldanamycin: a novel therapeutic approach for treating hormone-refractory prostate cancer. Clin Cancer Res. 8, 962-966.
Neckers, L. 2007. Heat shock protein 90: the cancer chaperone. J Biosci. 32, 517-530.
Newman, D.J., Cragg, G.M., Snader, K.M. 2003. Natural products as sources of new drugs over the period 1981-2002. J Nat Prod. 66, 1022-1037.
Nieves-Neira, W., Pommier, Y. 1999. Apoptotic response to camptothecin and 7-hydroxystaurosporine (UCN-01) in the 8 human breast cancer cell lines of the NCI Anticancer Drug Screen: multifactorial relationships with topoisomerase I, protein kinase C, Bcl-2, p53, MDM-2 and caspase pathways. Int J Cancer. 82, 396-404.
Nimmanapalli, R., Fuino, L., Bali, P., Gasparetto, M., Glozak, M., Tao, J., Moscinski, L., Smith, C., Wu, J., Jove, R., Atadja, P., Bhalla, K. 2003. Histone deacetylase inhibitor LAQ824 both lowers expression and promotes proteasomal degradation of Bcr-Abl and induces apoptosis of imatinib mesylate-sensitive or -refractory chronic myelogenous leukemia-blast crisis cells. Cancer Res. 63, 5126-5135.
Nordberg, J., Arner, E.S. 2001. Reactive oxygen species, antioxidants, and the mammalian thioredoxin system. Free Radic Biol Med. 31, 1287-1312.
O''Connor, D.S., Grossman, D., Plescia, J., Li, F., Zhang, H., Villa, A., Tognin, S., Marchisio, P.C. 2000. Altieri, D.C. Regulation of apoptosis at cell division by p34cdc2 phosphorylation of survivin. Proc Natl Acad Sci U S A. 97, 13103-13107.
Okada, H., Mak, T.W. 2004. Pathways of apoptotic and non-apoptotic death in tumour cells. Nat Rev Cancer. 8, 592-603.
Olie, R.A., Simões-Wüst, A.P., Baumann, B., Leech, S.H., Fabbro, D., Stahel, R.A., Zangemeister-Wittke, U. 2000. A novel antisense oligonucleotide targeting survivin expression induces apoptosis and sensitizes lung cancer cells to chemotherapy. Cancer Res. 60, 2805-2809.
Olopade, O.I., Adeyanju, M.O., Safa, A.R., Hagos, F., Mick, R., Thompson, C.B., Recant, W.M. 1997. Overexpression of BCL-x protein in primary breast cancer is associated with high tumor grade and nodal metastases. Cancer J Sci Am. 3, 230-237.
Ozben, T. 2007. Oxidative stress and apoptosis: impact on cancer therapy. J Pharm Sci. 96, 2181-2196.
Page, C., Lin, H.J., Jin, Y., Castle, V.P., Nunez, G., Huang, M., Lin, J. 2000. Overexpression of Akt/AKT can modulate chemotherapy-induced apoptosis. Anticancer Res. 20, 407-416.
Pelicano, H., Carney, D., Huang, P. 2004. ROS stress in cancer cells and therapeutic implications. Drug Resist Updat. 7, 97-110.
Pommier, Y., Sordet, O., Antony, S., Hayward, R.L., Kohn, K.W. 2004. Apoptosis defects and chemotherapy resistance: molecular interaction maps and networks. Oncogene. 23, 2934-2949.
Puthalakath, H., Strasser, A. 2002. Keeping killers on a tight leash: transcriptional and post-translational control of the pro-apoptotic activity of BH3-only proteins. Cell Death Differ. 9, 505-512.
Reed, J.C. 2001. Apoptosis-regulating proteins as targets for drug discovery. Trends Mol Med. 7, 314-319.
Rock, K. L., Gramm, C., Rothstein, L., Clark, K., Stein, R., Dick, L., Hwang, D., and Goldberg, A. L. 1994. Inhibitors of the proteasome block the degradation of most cell proteins and the generation of peptides presented on MHC class I molecules. Cell. 78, 761-771.
Runnebaum, I.B., Nagarajan, M., Bowman, M., Soto, D., Sukumar, S. 1991. Mutations in p53 as potential molecular markers for human breast cancer. Proc Natl Acad Sci U S A. 88, 10657-10661.
Saklani, A., Kutty, S.K. 2008. Plant-derived compounds in clinical trials. Drug Discov Today. 13, 161-171.
Savitsky, P.A., Finkel, T. 2002. Redox regulation of Cdc25C. J Biol Chem. 277, 20535-20540.
Schendel, S.L., Xie, Z., Montal, M.O., Matsuyama, S., Montal, M., Reed, J.C. 1997. Channel formation by antiapoptotic protein Bcl-2. Proc Natl Acad Sci U S A. 4, 5113-5118.
Schneider, C., Sepp-Lorenzino, L., Nimmesgern, E., Ouerfelli, O., Danishefsky, S., Rosen, N., Hartl, F.U. 1996. Pharmacologic shifting of a balance between protein refolding and degradation mediated by Hsp90. Proc Natl Acad Sci U S A. 93, 14536–14541.
Schumacher, R.J., Hurst, R., Sullivan, W.P., McMahon, N.J., Toft, D.O., Matts, R.L. 1994. ATP-dependent chaperoning activity of reticulocyte lysate. J Biol Chem. 269, 9493-9499.
Sellers, W.R., Fisher, D.E., 1999. Apoptosis and cancer drug targeting. J Clin Invest. 104, 1655-1661.
Sharan, S.K., Morimatsu, M., Albrecht, U., Lim, D.S., Regel, E., Dinh, C., Sands, A., Eichele, G., Hasty, P., Bradley, A. 1997. Embryonic lethality and radiation hypersensitivity mediated by Rad51 in mice lacking Brca2. Nature. 386, 804-810.
Sherr, C.J., Roberts, J.M. 1999. CDK inhibitors: positive and negative regulators of G1-phase progression. Genes Dev. 13, 1501-1512.
Sherr, C.J., Roberts, J.M., 1995. Inhibitors of mammalian G1 cyclin-dependent kinases. Genes Dev. 9, 1149-1163.
Shieh, S.Y., Ahn, J., Tamai, K., Taya, Y., Prives, C. 2000. The human homologs of checkpoint kinases Chk1 and Cds1 (Chk2) phosphorylate p53 at multiple DNA damage-inducible sites. Genes Dev. 14, 289-300.
Shin, S., Sung, B.J., Cho, Y.S., Kim, H.J., Ha, N.C., Hwang, J.I., Chung, C.W., Jung, Y.K., Oh, B.H. 2001. An anti-apoptotic protein human survivin is a direct inhibitor of caspase-3 and -7. Biochemistry. 40, 1117-1123.
Shrieve, D.C., Bump, E.A., Rice, G.C. 1988. Heterogeneity of cellular glutathione among cells derived from a murine fibrosarcoma or a human renal cell carcinoma detected by flow cytometric analysis. J Biol Chem. 263, 14107-14114.
Simizu, S., Takada, M., Umezawa, K., Imoto, M. 1998. Requirement of caspase-3(-like) protease-mediated hydrogen peroxide production for apoptosis induced by various anticancer drugs. J Biol Chem. 273, 26900-26907.
Smith, D.F., Toft, D.O. 1993. Steroid receptors and their associated proteins. Mol Endocrinol. 7, 4-11.
Smits, V.A., Medema, R.H. 2001. Checking out the G(2)/M transition. Biochim Biophys Acta. 1519, 1-12.
Sparano, J.A., Moulder, S., Kazi, A., Vahdat, L., Li, T., Pellegrino, C., Munster, P., Malafa, M., Lee, D., Hoschander, S., Hopkins, U., Hershman, D., Wright, J.J., Sebti, S.M. 2006. Targeted inhibition of farnesyltransferase in locally advanced breast cancer: a phase I and II trial of tipifarnib plus dose-dense doxorubicin and cyclophosphamide. J Clin Oncol. 24, 3013–3018.
Sreedhar, A. S., Soti, C., Csermely, P. 2004. Inhibition of Hsp90: a new strategy for inhibiting protein kinases. Biochim Biophys Acta. 1697, 233–242.
Srirangam, A., Mitra, R., Wang, M., Gorski, J.C., Badve, S., Baldridge, L., Hamilton, J., Kishimoto, H., Hawes, J., Li, L., Orschell, C.M., Srour, E.F., Blum, J.S., Donner, D., Sledge, G.W., Nakshatri, H., Potter, D.A. 2006. Effects of HIV protease inhibitor ritonavir on Akt-regulated cell proliferation in breast cancer. Clin Cancer Res. 12, 883-896.
Stewart, Z.A., Pietenpol, J.A. 2001. p53 Signaling and cell cycle checkpoints. Chem Res Toxicol. 3, 243-263.
Stewart, Z.A., Westfall, M.D., Pietenpol, J.A. 2003. Cell-cycle dysregulation and anticancer therapy. Trends Pharmacol Sci. 3, 139-145.
Sureda, F.X., Escubedo, E., Gabriel, C., Comas, J., Camarasa, J., CAmins, A. 1997. Mitochondria membrane potential measurement in rat cerebellar neurons by flow cytometry. Cytometry. 28, 74-80.
Susin, S.A., Lorenzo, H.K., Zamzami, N., Marzo, I., Brenner, C., Larochette, N., Prevost, M.C., Alzari, P.M., Kroemer, G. 1999. Mitochondrial release of caspase-2 and -9 during the apoptotic process. J Exp Med. 189, 381-394.
Takayama, S., Reed, J.C., Homma, S. 2003. Heat-shock proteins as regulators of apoptosis. Oncogene. 22, 9041-9047.
Taylor, W.R., Stark, G.R. 2001. Regulation of the G2/M transition by p53. Oncogene. 20, 1803-1815.
Tchou, W.W., Rom, W.N., Tchou-Wong, K.M. 1996. Novel form of p21(WAF1/CIP1/SDI1) protein in phorbol ester-induced G2/M arrest. J Biol Chem. 271, 29556-29560.
Thompson, E.W., Paik, S., Brunner, N., Sommers, C.L., Zugmaier, G., Clarke, R., Shima, T.B., Torri, J., Donahue, S., Lippman, M.E. 1992. Association of increased basement membrane invasiveness with absence of estrogen receptor and expression of vimentin in human breast cancer cell lines. J Cell Physiol. 150, 534-544.
Thornberry, N.A., Lazebnik, Y. 1998. Caspases: enemies within. Science. 281, 1312-6
Toyokuni, S., Okamoto, K., Yodoi, J., Hiai, H. 1995. Persistent oxidative stress in cancer. FEBS Lett. 358, 1-3.
Tsujimoto, Y., Shimizu, S. 2000. VDAC regulation by the Bcl-2 family of proteins. Cell Death Differ. 7, 1174-1181.
Tsujinaka, T., Kajiwara, Y., Kambayashi, J., Sakon, M, Higuchi, N., Tanaka, T., Mori, T. 1988. Synthesis of a new cell penetrating calpain inhibitor (calpeptin). Biochem Biophys Res Commun. 153, 1201-1208.
Turbyville, T.J., Wijeratne, E.M., Liu, M.X., Burns, A.M., Seliga, C.J., Luevano, L.A., David, C.L., Faeth, S.H., Whitesell, L., Gunatilaka, A.A. 2006. Search for Hsp90 inhibitors with potential anticancer activity: isolation and SAR studies of radicicol and monocillin I from two plant-associated fungi of the Sonoran desert. J Nat Prod. 69, 178-184.
Ueda, S., Masutani, H., Nakamura, H., Tanaka, T., Ueno, M., Yodoi, J. 2002. Redox control of cell death. Antioxid. Redox Signal. 4, 405-414.
Ueda, S., Nakamura, H., Masutani, H., Sasada, T., Yonehara, S., Takabayashi, A., Yamaoka, Y., Yodoi, J. 1998. Redox regulation of caspase-3(-like) protease activity: regulatory roles of thioredoxin and cytochrome c. J Immunol. 161, 6689-6695.
Varfolomeev, E.E., Schuchmann, M., Luria, V., Chiannilkulchai, N., Beckmann, J.S., Mett, I.L., Rebrikov, D., Brodianski, V.M., Kemper, O.C., Kollet, O., Lapidot, T., Soffer, D., Sobe, T., Avraham, K.B., Goncharov, T., Holtmann, H., Lonai, P., Wallach, D. 1998. Targeted disruption of the mouse caspase8 gene ablates cell death induction by the TNF receptors, Fas/Apo1, and DR3 and is lethal prenataly. Immunity 9, 267–276.
Walker, J.V., Nitiss, J.L. 2002. DNA topoisomerase II as a target for cancer chemotherapy. Cancer Invest. 20, 570–589.
Wallach, D., Varfolomeev, E. E., Malinin, N. L., Goltsev, Y. V., Kovalenko, A. V., Boldin, M. P. 1999. Tumor necrosis factor receptor and Fas signaling mechanisms. Annu Rev Immunol. 17, 331–36
Wegele, H., Müller, L., Buchner, J. 2004. Hsp70 and Hsp90--a relay team for protein folding. Rev. Physiol. Biochem Pharmacol. 151, 1-44.
Whitesell, L., Lindquist, S.L. 2005. HSP90 and the chaperoning of cancer. Nat Rev Cancer. 10, 761-772.
Whitesell, L., Mimnaugh, E.G., DeCosta, B., Myers, C.E., Neckers, L.M. 1994. Inhibition of heat shock protein HSP90-pp60v-src heteroprotein complex formation by benzoquinone ansamycins: essential role for stress proteins in oncogenic transformation. Proc Natl Acad Sci U S A. 91, 8324–8328.
Wright, L., Barril, X., Dymock, B., Sheridan, L., Surgenor, A., Beswick, M., Drysdale, M., Collier, A., Massey, A., Davies, N., Fink, A., Fromont, C., Aherne, W., Boxall, K., Sharp, S., Workman, P., Hubbard, R.E. 2004. Structure-activity relationships in purine-based inhibitor binding to HSP90 isoforms. Chem Biol. 11, 775-785.
Wu, C. 1995. Heat shock transcription factors: structure and regulation. Annu Rev Cell Dev Biol.11, 441-469.
Xia, Z., Lundgren, B., Bergstrand, A., DePropidium iodideerre, J.W., Nassberger, L., 1999. Changes in the generation of reactive oxygen species and in mitochondrial membrane potential during apoptosis induced by the antidepressants imipramine, clomipramine, and citalopram and the effects on these changes by Bcl-2 and Bcl-X(L). Biochem Pharmacol. 57, 1199-1208.
Yamamoto, K., Ichijo, H., Korsmeyer, S.J. 1999. BCL-2 is phosphorylated and inactivated by an ASK1/Jun N-terminal protein kinase pathway normally activated at G2/M. Mol Cell Biol. 19, 8469-8478.
Yokomizo, A., Ono, M., Nanri, H., Makino, Y., Ohga, T., Wada, M., Okamoto, T., Yodoi, J., Kuwano, M., Kohno, K. 1995. Cellular levels of thioredoxin associated with drug sensitivity to cisplatin, mitomycin C, doxorubicin, and etoposide. Cancer Res. 55, 4293-4296.
Yokota, Y., Bargagna-Mohan, P., Ravindranath, P.P., Kim, K.B., Mohan, R. 2006. Development of withaferin A analogs as probes of angiogenesis. Bioorg Med Chem Lett. 16, 2603-2607.
Yufu, Y., Nishimura, J., Nawata, H. 1992. High constitutive expression of heat shock protein 90 alpha in human acute leukemia cells. Leuk Res. 16, 597-605.
Yun, B.G., Huang, W., Leach, N., Hartson, S.D., Matts, R.L. 2004. Novobiocin induces a distinct conformation of Hsp90 and alters Hsp90-cochaperone-client interactions. Biochemistry. 43, 8217-8229.
Zaarur, N., Gabai, V.L, Porco, J.A. Jr., Calderwood, S., Sherman, M.Y. 2006. Targeting heat shock response to sensitize cancer cells to proteasome and Hsp90 inhibitors. Cancer Res. 66, 1783-1791.
Zamzami, N., Marchetti, P., Castedo, M., Decaudin, D., Macho, A., Hirsch, T., Susin, S.A., Petit, P.X., Mignotte, B., Kroemer, G. 1995. Sequential reduction of mitochondrial transmembrane potential and generation of reactive oxygen species in early programmed cell death. J Exp Med. 182, 367-377.
Zha, J., Harada, H., Yang, E., Jockel, J., Korsmeyer, S.J. 1996. Serine phosphorylation of death agonist BAD in response to survival factor results in binding to 14-3-3 not BCL-X(L) Cell. 87, 619-628.
Zhang, H., Burrows, F. 2004. Targeting multiple signal transduction pathways through inhibition of Hsp90. J Mol Med. 82, 88-99.
Zhang, Z., Leonard, S.S., Huang, C., Vallyathan, V., Castranova, V., Shi, X. 2003. Role of reactive oxygen species and MAPKs in vanadate-induced G(2)/M phase arrest. Free Radic Biol. Med. 34, 1333-1342.
Zheng, L., Lee, W.H. 2001. The retinoblastoma gene: a prototypic and multifunctional tumor suppressor. Exp Cell Res. 264, 2-18.
Zou, H., Li, Y., Liu, X., Wang, X. 1999. An APAF-1 cytochrome c multimeric complex is a functional apoptosome that activates procaspase-9. J Biol Chem. 274, 11549-11556.
|